Myasthenia gravis-associated ryanodine receptor antibodies inhibit binding of ryanodine to sarcoplasmic reticulum

Ann N Y Acad Sci. 1998 May 13:841:530-3. doi: 10.1111/j.1749-6632.1998.tb10976.x.

Authors

G O Skeie¹, P K Lunde, O M Sejersted, A Mygland, J A Aarli, N E Gilhus

Affiliation

¹ Department of Neurology, University of Bergen, Norway.

PMID: 9668288
DOI: 10.1111/j.1749-6632.1998.tb10976.x

No abstract available

MeSH terms

Autoantibodies / blood*
Autoantibodies / pharmacology
Binding, Competitive
Calcium Channel Blockers*
Humans
Muscle, Skeletal / metabolism
Myasthenia Gravis / complications
Myasthenia Gravis / immunology*
Ryanodine / metabolism*
Ryanodine Receptor Calcium Release Channel / immunology*
Ryanodine Receptor Calcium Release Channel / isolation & purification
Ryanodine Receptor Calcium Release Channel / metabolism
Sarcoplasmic Reticulum / metabolism
Thymoma / complications
Thymoma / immunology*
Thymus Neoplasms / complications
Thymus Neoplasms / immunology*

Substances

Autoantibodies
Calcium Channel Blockers
Ryanodine Receptor Calcium Release Channel
Ryanodine